All Blog Posts

The classification of gliomas is changing profoundly, shifting from a morphology-based guide to a system based on molecular criteria, built around their genomic landscape and data from next-generation sequencing. Read more to learn about the key molecular markers that allow the latest classification of gliomas.

Our new Research Roundup summarises three cancer research studies that have used polyclonal antibodies from Atlas Antibodies. Today we share insights into a new biomarker for glioma, the metastatic process in colorectal cancer, and the effect of ginseng metabolites on cancer cells proliferation. Learn more!

T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better.

Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition.

This year marks a major milestone for Atlas Antibodies, as it will be 15 years since we started our journey by launching our antibodies webshop. There are many more milestones we want to share with you. Keep reading!

Want to see our antibodies in action? Keep reading our latest Research Roundup! The following three studies have successfully utilized Atlas Antibodies products in stem cell research.

In this blog post, we share bits of evidence about the involvement of voltage-gated ion channels in human cancers, highlighting their promising use as biomarkers. Read on!

The next person to participate in our employee spotlight series is Joel Svenson, our new product manager for the monoclonal product portfolio. In his interview, Joel shares his thoughts on why he decided to join Atlas Antibodies, what his first months at the company have been like, and what he is looking forward to in the future. Keep reading to get to know Joel and his exciting new position a little bit more in-depth.

Check out this interview with Atlas Antibodies' Principal Scientist, Dr. Eugenia Kuteeva, to hear how our monoclonal antibodies advance discoveries in neurodegenerative diseases. The interview is published on Neuro Central, an online resource powered by Future Science Group.

International Men's Health Week is celebrated worldwide on June 14–20. The week raises awareness of the importance of health and wellness for boys and men. To honor this week, we asked two Atlas Antibodies' employees their views on health and how they see the importance of maintaining good health in their individual lives. Read on to hear from Jonatan and Jonathan on how important good health is to them.